Monday, June 6, 2016

Early assessment, drug switch improves cancer treatment

… NewYork-Presbyterian.
Patients with progressive metastatic prostate cancer following hormonal therapy are typically … . Though the drugs are similar, tumors that are resistant to one … trial assessing response rates among prostate cancer patients who switched from docetaxel …

No comments:

Post a Comment